<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934
or
Suspension of Duty to File Reports Under Sections 13 and 15(d) of the
Securities Exchange Act of 1934
Commission File Number: 0-19193
CAMBRIDGE NEUROSCIENCE, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
333 PROVIDENCE HIGHWAY, NORWOOD, MASSACHUSETTS 02062 (781) 255-6700
--------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
COMMON STOCK, $.001 PAR VALUE PER SHARE
--------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
NONE
--------------------------------------------------------------------------------
(Title of all other classes for which a duty to file reports under section 13(a)
or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(i) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certificate or notice date:
one
Pursuant to the requirements of the Securities Exchange Act of 1934, Cambridge
NeuroScience, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Date: December 18, 2000 By: /s/ Robert N. McBurney
----------------------------------------
Robert N. McBurney
President and Chief Executive Officer
